HAL (France)
open access
Understanding dopaminergic dose reduction following STN-DBS: mediation analysis
Background: Levodopa equivalent dopaminergic dose (LEDD) reduction after subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson's disease varies widely. Identifying predictors may guide patient selection and programming. Our objectives were to identify predictors of LEDD reduction and to
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Neuropsychological outcomes comparing deep brain stimulation and best medical treatment for Parkinson's disease: a systematic review and meta-analysis.#338333
- Study of the Effect of SR57667B on the Progression of Symptoms in Patients With Parkinson's Disease#982718
- Improvement of apathy in early Parkinson’s disease#1166324
- Common Noradrenergic Mechanisms in Parkinson´s Disease and L-DOPA Induced Dyskinesia#854073
- Hub and Spoke, Comparative Outcomes for Parkinson's Disease Treated With Deep Brain Stimulation#1350720
Record · ID 1329050
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive